206 related articles for article (PubMed ID: 28300834)
21. Manipulation of reciprocal salt bridges at the heterodimerization interface alters the dimerization properties of mouse RXRalpha and PPARgamma1.
Chan LS; Wells RA
Biochem Biophys Res Commun; 2007 Jul; 358(4):1080-5. PubMed ID: 17521607
[TBL] [Abstract][Full Text] [Related]
22. New PPARG mutation leads to lipodystrophy and loss of protein function that is partially restored by a synthetic ligand.
Lüdtke A; Buettner J; Schmidt HH; Worman HJ
J Med Genet; 2007 Sep; 44(9):e88. PubMed ID: 17766367
[TBL] [Abstract][Full Text] [Related]
23. Peroxisome proliferator-activated receptor-gamma C190S mutation causes partial lipodystrophy.
Lüdtke A; Buettner J; Wu W; Muchir A; Schroeter A; Zinn-Justin S; Spuler S; Schmidt HH; Worman HJ
J Clin Endocrinol Metab; 2007 Jun; 92(6):2248-55. PubMed ID: 17356052
[TBL] [Abstract][Full Text] [Related]
24. A naturally occurring rexinoid, honokiol, can serve as a regulator of various retinoid x receptor heterodimers.
Kotani H; Tanabe H; Mizukami H; Amagaya S; Inoue M
Biol Pharm Bull; 2012; 35(1):1-9. PubMed ID: 22223330
[TBL] [Abstract][Full Text] [Related]
25. Analysis of C. elegans NR2E nuclear receptors defines three conserved clades and ligand-independent functions.
Weber KP; Alvaro CG; Baer GM; Reinert K; Cheng G; Clever S; Wightman B
BMC Evol Biol; 2012 Jun; 12():81. PubMed ID: 22690911
[TBL] [Abstract][Full Text] [Related]
26. The loss of transcriptional inhibition by the photoreceptor-cell specific nuclear receptor (NR2E3) is not a necessary cause of enhanced S-cone syndrome.
Fradot M; Lorentz O; Wurtz JM; Sahel JA; Léveillard T
Mol Vis; 2007 Apr; 13():594-601. PubMed ID: 17438525
[TBL] [Abstract][Full Text] [Related]
27. T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.
Lee G; Elwood F; McNally J; Weiszmann J; Lindstrom M; Amaral K; Nakamura M; Miao S; Cao P; Learned RM; Chen JL; Li Y
J Biol Chem; 2002 May; 277(22):19649-57. PubMed ID: 11877444
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor gamma as modulator of inflammation in pulmonary sarcoidosis.
Pejcić T; Stanković I; Petković TR; Borovac DN; Djordjević I; Jeftović-Stoimenov T
Srp Arh Celok Lek; 2013; 141(9-10):705-9. PubMed ID: 24364239
[TBL] [Abstract][Full Text] [Related]
29. Sphingosine 1-phosphate is a ligand for peroxisome proliferator-activated receptor-γ that regulates neoangiogenesis.
Parham KA; Zebol JR; Tooley KL; Sun WY; Moldenhauer LM; Cockshell MP; Gliddon BL; Moretti PA; Tigyi G; Pitson SM; Bonder CS
FASEB J; 2015 Sep; 29(9):3638-53. PubMed ID: 25985799
[TBL] [Abstract][Full Text] [Related]
30. Photoreceptor-specific nuclear receptor NR2E3 functions as a transcriptional activator in rod photoreceptors.
Cheng H; Khanna H; Oh EC; Hicks D; Mitton KP; Swaroop A
Hum Mol Genet; 2004 Aug; 13(15):1563-75. PubMed ID: 15190009
[TBL] [Abstract][Full Text] [Related]
31. Specificity of DNA-binding by the FAX-1 and NHR-67 nuclear receptors of Caenorhabditis elegans is partially mediated via a subclass-specific P-box residue.
DeMeo SD; Lombel RM; Cronin M; Smith EL; Snowflack DR; Reinert K; Clever S; Wightman B
BMC Mol Biol; 2008 Jan; 9():2. PubMed ID: 18179707
[TBL] [Abstract][Full Text] [Related]
32. Altering PPARgamma ligand selectivity impairs adipogenesis by thiazolidinediones but not hormonal inducers.
Samarasinghe SP; Sutanto MM; Danos AM; Johnson DN; Brady MJ; Cohen RN
Obesity (Silver Spring); 2009 May; 17(5):965-72. PubMed ID: 19165156
[TBL] [Abstract][Full Text] [Related]
33. A peroxisome proliferator-activated receptor gamma-retinoid X receptor heterodimer physically interacts with the transcriptional activator PAX6 to inhibit glucagon gene transcription.
Krätzner R; Fröhlich F; Lepler K; Schröder M; Röher K; Dickel C; Tzvetkov MV; Quentin T; Oetjen E; Knepel W
Mol Pharmacol; 2008 Feb; 73(2):509-17. PubMed ID: 17962386
[TBL] [Abstract][Full Text] [Related]
34. Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects.
Berger J; Leibowitz MD; Doebber TW; Elbrecht A; Zhang B; Zhou G; Biswas C; Cullinan CA; Hayes NS; Li Y; Tanen M; Ventre J; Wu MS; Berger GD; Mosley R; Marquis R; Santini C; Sahoo SP; Tolman RL; Smith RG; Moller DE
J Biol Chem; 1999 Mar; 274(10):6718-25. PubMed ID: 10037770
[TBL] [Abstract][Full Text] [Related]
35. NR2E3 mutations in enhanced S-cone sensitivity syndrome (ESCS), Goldmann-Favre syndrome (GFS), clumped pigmentary retinal degeneration (CPRD), and retinitis pigmentosa (RP).
Schorderet DF; Escher P
Hum Mutat; 2009 Nov; 30(11):1475-85. PubMed ID: 19718767
[TBL] [Abstract][Full Text] [Related]
36. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
[TBL] [Abstract][Full Text] [Related]
37. Nuclear receptors in disease: thyroid receptor beta, peroxisome-proliferator-activated receptor gamma and orphan receptors.
Gurnell M; Chatterjee VK
Essays Biochem; 2004; 40():169-89. PubMed ID: 15242346
[TBL] [Abstract][Full Text] [Related]
38. Structural basis of the transactivation deficiency of the human PPARγ F360L mutant associated with familial partial lipodystrophy.
Lori C; Pasquo A; Montanari R; Capelli D; Consalvi V; Chiaraluce R; Cervoni L; Loiodice F; Laghezza A; Aschi M; Giorgi A; Pochetti G
Acta Crystallogr D Biol Crystallogr; 2014 Jul; 70(Pt 7):1965-76. PubMed ID: 25004973
[TBL] [Abstract][Full Text] [Related]
39. Peroxisome proliferator-activated receptor gamma (PPARγ) has multiple binding points that accommodate ligands in various conformations: Structurally similar PPARγ partial agonists bind to PPARγ LBD in different conformations.
Ohashi M; Gamo K; Oyama T; Miyachi H
Bioorg Med Chem Lett; 2015 Jul; 25(14):2758-62. PubMed ID: 26025876
[TBL] [Abstract][Full Text] [Related]
40. Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate.
Haider NB; Jacobson SG; Cideciyan AV; Swiderski R; Streb LM; Searby C; Beck G; Hockey R; Hanna DB; Gorman S; Duhl D; Carmi R; Bennett J; Weleber RG; Fishman GA; Wright AF; Stone EM; Sheffield VC
Nat Genet; 2000 Feb; 24(2):127-31. PubMed ID: 10655056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
